Preoperative antithrombin III activity predicts outcome after surgical repair of acute type A aortic dissection

Ehrlich, 2000, Results of immediate surgical treatment of all acute type A dissections, Circulation, 102, 248 Hagan, 2000, The International Registry of Acute Aortic Dissection (IRAD): new insights into an old disease, JAMA, 283, 897, 10.1001/jama.283.7.897 Mehta, 2002, Predicting death in patients with acute type a aortic dissection, Circulation, 105, 200, 10.1161/hc0202.102246 Ehrlich, 2003, Predictors of adverse outcome and transient neurological dysfunction following surgical treatment of acute type A dissections, Circulation, 108, 318 Ehrlich, 1998, Perioperative risk factors for mortality in patients with acute type A aortic dissection, Circulation, 98, 294 Trimarchi, 2003, Preoperative predictive risk model for mortality in patients with acute type A aortic dissection undergoing surgery: lessons from the International Registry of Acute Aortic Dissection (IRAD), J Am Coll Cardiol, 41, 512, 10.1016/S0735-1097(03)82772-9 Mehta, 2002, Acute type A aortic dissection in the elderly: clinical characteristics, management, and outcomes in the current era, J Am Coll Cardiol, 40, 685, 10.1016/S0735-1097(02)02005-3 Bossone, 2002, Usefulness of pulse deficit to predict in-hospital complications and mortality in patients with acute type A aortic dissection, Am J Cardiol, 89, 851, 10.1016/S0002-9149(02)02198-7 Koster, 2002, Hemostatic activation and inflammatory response during cardiopulmonary bypass: impact of heparin management, Anesthesiology, 97, 837, 10.1097/00000542-200210000-00014 Schillinger, 2002, C-reactive protein and mortality in patients with acute aortic disease, Intensive Care Med, 28, 740, 10.1007/s00134-002-1299-1 Kilger, 2003, Stress doses of hydrocortisone reduce severe systemic inflammatory response syndrome and improve early outcome in a risk group of patients after cardiac surgery, Crit Care Med, 31, 1068, 10.1097/01.CCM.0000059646.89546.98 Warren, 2001, Caring for the critically ill patient. High-dose antithrombin III in severe sepsis: a randomized controlled trial, JAMA, 286, 1869, 10.1001/jama.286.15.1869 Eisele, 1998, Antithrombin III in patients with severe sepsis. A randomized, placebo-controlled, double-blind multicenter trial plus a meta-analysis on all randomized, placebo-controlled, double-blind trials with antithrombin III in severe sepsis, Intensive Care Med, 24, 663, 10.1007/s001340050642 Inthorn, 1998, Effect of antithrombin III supplementation on inflammatory response in patients with severe sepsis, Shock, 10, 90, 10.1097/00024382-199808000-00002 Lane, 1997, Antithrombin mutation database: 2nd (1997) update. For the Plasma Coagulation Inhibitors Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis, Thromb Haemost, 77, 197, 10.1055/s-0038-1655930 Erbel, 2001, Task force of the ESC: diagnosis and management of aortic dissection, Eur Heart J, 22, 1642, 10.1053/euhj.2001.2782 Levy, 2003, Crit Care Med, 31, 1250, 10.1097/01.CCM.0000050454.01978.3B Lechner, 1995, Antithrombin III concentrates—are they clinically useful?, Thromb Haemost, 73, 340, 10.1055/s-0038-1653778 Weber, 2003, D-dimer in acute aortic dissection, Chest, 123, 1375, 10.1378/chest.123.5.1375 Adam, 2002, Hemostatic markers before operation in patients with acutely symptomatic nonruptured and ruptured infrarenal abdominal aortic aneurysm, J Vasc Surg, 35, 661, 10.1067/mva.2002.121755 Ranucci, 2002, The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits, J Cardiothorac Vasc Anesth, 16, 316, 10.1053/jcan.2002.124140